Penumbra Inc. Company Profile
NYSE: PENHealth CareMedical/Dental InstrumentsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Penumbra at a glance
Penumbra Inc. (NYSE: PEN) is a Medical/Dental Instruments company in the Health Care sector headquartered in Alameda, CA. Penumbra is led by Mr. Adam Elsesser J.D. and employs about 4,700 people. The company's shares have traded publicly since 2015.
At a market capitalization of $12.49 billion, it is considered a large-cap company. Its SEC Central Index Key (CIK) is 0001321732, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Penumbra do?
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.
Business description based on the company's public filings.
Company information
- Legal name
- Penumbra Inc.
- Ticker
- NYSE: PEN
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Mr. Adam Elsesser J.D.
- Employees
- 4,700
- Headquarters
- One Penumbra Place, Alameda, CA, United States
- Phone
- 510 748 3200
- Website
- penumbrainc.com
- IPO year
- 2015
- Market cap
- $12.49B
- SEC CIK
- 0001321732
- Latest annual report
- 10-K · Feb 25, 2026
Companies similar to Penumbra
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| BAXBaxter International Inc. | 23.97 | -1.60% | $12.39B | vs PEN |
| SOLVSolventum Corporation | 85.88 | -1.33% | $14.62B | vs PEN |
| GKOSGlaukos Corporation | 172.18 | +6.55% | $10.16B | vs PEN |
| GMEDGlobus Medical Inc. Class A | 73.75 | -3.51% | $9.90B | vs PEN |
| PODDInsulet Corporation | 134.36 | -0.27% | $9.32B | vs PEN |
| MMEDMiniMed Group Inc. | 19.11 | -2.70% | $5.38B | vs PEN |
| STVNStevanato Group S.p.A. | 19.44 | -2.11% | $5.31B | vs PEN |
| TFXTeleflex Incorporated | 124.48 | -0.21% | $5.27B | vs PEN |